Adenylate cyclase activity of Pseudomonas aeruginosa ExoY can mediate bleb-niche formation in epithelial cells and contributes to virulence

Microbial Pathogenesis

Volumn 51, Issue 5, 2011, Pages 305-312

  Hritonenko, Victoria ^a   Mun, James J ^a   Tam, Connie ^a   Simon, Nathan C ^b   Barbieri, Joseph T ^b   Evans, David J ^a,c   Fleiszig, Suzanne M J ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c TOURO UNIVERSITY CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adenylate cyclase; Cornea; Epithelial cells; ExoY; Intracellular survival; Membrane blebs; Pseudomonas aeruginosa; Virulence

Indexed keywords

ADENYLATE CYCLASE; BACTERIAL TOXIN; BACTERIAL TOXIN EXOY; UNCLASSIFIED DRUG;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; CELL TRANSPORT; CHROMOSOME; CONTROLLED STUDY; CORNEA BLEB NICHE FORMATION; CORNEA DISEASE; CORNEA EPITHELIUM; ENZYME ACTIVITY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IN VIVO STUDY; KERATITIS; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA;

ADENYLATE CYCLASE; ANIMALS; BACTERIAL PROTEINS; CELL LINE; CELL MEMBRANE; EPITHELIAL CELLS; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; PROTEIN STRUCTURE, TERTIARY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; VIRULENCE;

BACTERIA (MICROORGANISMS); MURINAE; MUS; PSEUDOMONAS AERUGINOSA;

EID: 80052433053     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2011.08.001     Document Type: Article

References (28)

1. Agrafiotis M., Siempos, Falagas M.E. Infections related to airway stenting: a systematic review. Respiration 2009, 78:69-74.
2. Willcox M.D. Pseudomonas aeruginosa infection and inflammation during contact lens wear: a review. Optom Vis Sci 2007, 84:273-278.
3. Wagner V.E., Iglewski B.H. P. aeruginosa biofilms in CF infection. Clin Rev Allergy Immunol 2008, 35:124-134.
4. Kerr K.G., Snelling A.M. Pseudomonas aeruginosa: a formidable and ever-present adversary. J Hosp Infect 2009, 73:338-344.
5. Engel J., Balachandran P. Role of Pseudomonas aeruginosa type III effectors in disease. Curr Opin Microbiol 2009, 12:61-66.
6. Hauser A.R. The type III secretion system of Pseudomonas aeruginosa: infection by injection. Nat Rev Microbiol 2009, 7:654-665.
7. Barbieri J.T., Sun J. Pseudomonas aeruginosa ExoS and ExoT. Rev Physiol Biochem Pharmacol 2004, 152:79-92.
8. Lee E.J., Cowell B.A., Evans D.J., Fleiszig S.M. Contribution of ExsA-regulated factors to corneal infection by cytotoxic and invasive Pseudomonas aeruginosa in a murine scarification model. Invest Ophthalmol Vis Sci 2003, 44:3892-3898.
9. Shaver C.M., Hauser A.R. Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung. Infect Immun 2004, 72:6969-6977.
10. Yahr T.L., Vallis A.J., Hancock M.K., Barbieri J.T., Frank D.W. ExoY, an adenylate cyclase secreted by the Pseudomonas aeruginosa type III system. Proc Natl Acad Sci U S A 1998, 95:13899-13904.
11. Prasain N., Alexeyev M., Balczon R., Stevens T. Soluble adenylyl cyclase-dependent microtubule disassembly reveals a novel mechanism of endothelial cell retraction. Am J Physiol Lung Cell Mol Physiol 2009, 297:L73-L83.
12. Vallis A.J., Finck-Barbancon V., Yahr T.L., Frank D.W. Biological effects of Pseudomonas aeruginosa type III-secreted proteins on CHO cells. Infect Immun 1999, 67:2040-2044.
13. Cowell B.A., Evans D.J., Fleiszig S.M. Actin cytoskeleton disruption by ExoY and its effects on Pseudomonas aeruginosa invasion. FEMS Microbiol Lett 2005, 250:71-76.
14. Sato H., Frank D.W. ExoU is a potent intracellular phospholipase. Mol Microbiol 2004, 53:1279-1290.
15. Finck-Barbancon V., Goranson J., Zhu L., Sawa T., Wiener-Kronish J.P., Fleiszig S.M., et al. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury. Mol Microbiol 1997, 25:547-557.
16. Zolfaghar I., Evans D.J., Ronaghi R., Fleiszig S.M. Type III secretion-dependent modulation of innate immunity as one of multiple factors regulated by Pseudomonas aeruginosa RetS. Infect Immun 2006, 74:3880-3889.
17. Tam C., Lewis S.E., Li W.Y., Lee E., Evans D.J., Fleiszig S.M. Mutation of the phospholipase catalytic domain of the Pseudomonas aeruginosa cytotoxin ExoU abolishes colonization promoting activity and reduces corneal disease severity. Exp Eye Res 2007, 85:799-805.
18. Fleiszig S.M., Wiener-Kronish J.P., Miyazaki H., Vallas V., Mostov K.E., Kanada D., et al. Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S. Infect Immun 1997, 65:579-586.
19. Angus A.A., Lee A.A., Augustin D.K., Lee E.J., Evans D.J., Fleiszig S.M. Pseudomonas aeruginosa induces membrane blebs in epithelial cells, which are utilized as a niche for intracellular replication and motility. Infect Immun 2008, 76:1992-2001.
20. Angus A.A., Evans D.J., Barbieri J.T., Fleiszig S.M. The ADP-ribosylation domain of Pseudomonas aeruginosa ExoS is required for membrane bleb niche formation and bacterial survival within epithelial cells. Infect Immun 2010, 78:4500-4510.
21. Lee E.J., Evans D.J., Fleiszig S.M. Role of Pseudomonas aeruginosa ExsA in penetration through corneal epithelium in a novel in vivo model. Invest Ophthalmol Vis Sci 2003, 44:5220-5227.
22. Alarcon I., Tam C., Mun J.J., Ledue J., Evans D.J., Fleiszig S.M. Factors impacting corneal epithelial barrier function against Pseudomonas aeruginosa traversal. Invest Ophthalmol Vis Sci 2011.
23. Sayner S.L., Frank D.W., King J., Chen H., VandeWaa J., Stevens T. Paradoxical cAMP-induced lung endothelial hyperpermeability revealed by Pseudomonas aeruginosa ExoY. Circ Res 2004, 95:196-203.
24. Vance R.E., Rietsch A., Mekalanos J.J. Role of the type III secreted exoenzymes S, T, and Y in systemic spread of Pseudomonas aeruginosa PAO1 in vivo. Infect Immun 2005, 73:1706-1713.
25. Lee V.T., Smith R.S., Tummler B., Lory S. Activities of Pseudomonas aeruginosa effectors secreted by the Type III secretion system in vitro and during infection. Infect Immun 2005, 73:1695-1705.
26. Robertson D.M., Li L., Fisher S., Pearce V.P., Shay J.W., Wright W.E., et al. Characterization of growth and differentiation in a telomerase-immortalized human corneal epithelial cell line. Invest Ophthalmol Vis Sci 2005, 46:470-478.
27. Knight D.A., Barbieri J.T. Ecto-ADP-ribosyltransferase activity of Pseudomonasaeruginosa exoenzyme S. Infect Immun 1997, 65:3304-3309.
28. Liu S., Kulich S.M., Barbieri J.T. Identification of glutamic acid 381 as a candidate active site residue of Pseudomonas aeruginosa exoenzyme S. Biochemistry 1996, 35:2754-2758.